Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
5,178,909
-
Shares change
-
-84,371
-
Total reported value, excl. options
-
$859,978,174
-
Value change
-
-$14,178,042
-
Put/Call ratio
-
0%
-
Number of buys
-
92
-
Number of sells
-
-99
-
Price
-
$166.06
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2021
255 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q3 2021.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,178,909 shares
.
Largest 10 shareholders include MORGAN STANLEY (843,326 shares), WELLS FARGO & COMPANY/MN (595,957 shares), BANK OF AMERICA CORP /DE/ (475,929 shares), UBS Group AG (383,661 shares), LPL Financial LLC (285,932 shares), Raymond James Financial Services Advisors, Inc. (201,235 shares), ROYAL BANK OF CANADA (191,292 shares), RAYMOND JAMES & ASSOCIATES (149,661 shares), ADVISOR GROUP HOLDINGS, INC. (141,187 shares), and COMMONWEALTH EQUITY SERVICES, LLC (129,068 shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.